Works matching IS 02704137 AND DT 2019 AND VI 79 AND IP 13


Results: 12
    1
    2
    3
    4
    5
    6
    7

    AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration‐resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first‐line therapy.

    Published in:
    Prostate, 2019, v. 79, n. 13, p. 1553, doi. 10.1002/pros.23875
    By:
    • Zhao, Jinge;
    • Zhang, Mengni;
    • Liu, Jiandong;
    • Liu, Zhenhua;
    • Shen, Pengfei;
    • Nie, Ling;
    • Guo, Wenhao;
    • Cai, Diming;
    • Liu, Jiyan;
    • Armstrong, Cameron M.;
    • Sun, Guangxi;
    • Chen, Junru;
    • Zhu, Sha;
    • Dai, Jindong;
    • Zhang, Haoran;
    • Zhao, Peng;
    • Zhang, Xingming;
    • Yin, Xiaoxue;
    • Zhu, Xudong;
    • Ni, Yuchao
    Publication type:
    Article
    8
    9
    10

    Preliminary results of a <sup>68</sup>Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making.

    Published in:
    Prostate, 2019, v. 79, n. 13, p. 1514, doi. 10.1002/pros.23869
    By:
    • Rousseau, Caroline;
    • Le Thiec, Maelle;
    • Ferrer, Ludovic;
    • Rusu, Daniela;
    • Rauscher, Aurore;
    • Maucherat, Bruno;
    • Frindel, Mathieu;
    • Baumgartner, Pierre;
    • Fleury, Vincent;
    • Denis, Antoine;
    • Morel, Agnes;
    • Varmenot, Nicolas;
    • Debeaupuis, Emilie;
    • Campion, Loic;
    • Kraeber‐Bodéré, Francoise
    Publication type:
    Article
    11
    12

    Issue Information.

    Published in:
    Prostate, 2019, v. 79, n. 13, p. 1487, doi. 10.1002/pros.23680
    Publication type:
    Article